RxDoctor Payments Data

Kenneth Giraldo

Interventional Pain Management · Sarasota, FLNPI 1326032061

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $15,000 of the $19,267 with a category attached, or 77.9%. 18 manufacturers reported payments, led by Foundation Fusion Solutions, LLC at 42.9% of the total. 2025 is the largest year on record at $8,751, more than ten times the $47 reported in 2019.

$19,267in general payments, 2019–2025

Across 67 payments — averaging $287.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Foundation Fusion Solutions, LLC$8K
  • Nutech Spine, Inc.$8K
  • Nalu Medical, Inc.$1K
  • Zentech Inc.$1K
  • Boston Scientific$584
  • Abbott$138
  • plus $471 from 12 others
$16,700in research payments, 2019–2025

Across 19 payments — averaging $878.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Foundation Fusion Solutions, LLC$17K

What the payments were for

  • Consulting fees$15,00078%
  • Travel & lodging$1,6058%
  • Food & beverage$2,55813%
  • Entertainment$1031%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few interventional pain management providers in Floridato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$415,247
Medicare patients
602
Services billed
4,024

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NucyntaTapentadol Hcl13$18,740
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen143$5,419
Gabapentin440$5,086
Oxymorphone Hcl ErOxymorphone Hcl12$4,802
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen176$3,461
Morphine Sulfate55$3,019
Tramadol Hcl330$2,414
Morphine Sulfate ErMorphine Sulfate86$2,128
Pregabalin67$1,489
Duloxetine Hcl31$1,093
Hydromorphone Hcl63$900
Tizanidine Hcl65$695
Diclofenac Sodium35$373
Baclofen13$326
Meloxicam64$161

Paid to pharmacies, not to this prescriber.

Other interventional pain management in Sarasota

Where these figures come from

Is this you, or does something look wrong? →